Emilie Brûlé

Emilie Brûlé

Auto-generated profile, based on publicly available information

Emilie Brûlé

Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2025 in Science
Verified
Journal Article
Closed access
LOLuisina Ongaro
Luisina Ongaro
XZXiang Zhou
Xiang Zhou
YWYing Wang
Ying Wang
HSHailey Schultz
Hailey Schultz
ZZZiyue Zhou
Ziyue Zhou
DBDaniel J. Bernard
Daniel J. Bernard
Myostatin is a paracrine myokine that regulates muscle mass in a variety of species, including humans. In this work, we report a functional role for myostatin as an endocrine hormone that directly promotes pituitary follicle-stimulating hormone (FSH) synthesis and thereby ovarian function in mice. Previously, this FSH-stimulating role was attributed to other members of the transforming growth factor–β family, the activins. Our results both challenge activin’s eponymous role in FSH synthesis and establish an unexpected endocrine axis between skeletal muscle and the pituitary gland. Our data also suggest that efforts to antagonize myostatin to increase muscle mass may have unintended consequences on fertility.

17 December 2021 in Science Advances
Verified
Journal Article
Open access
EBEmilie Brûlé
Emilie Brûlé
YWYing Wang
Ying Wang
YLYining Li
Yining Li
YLYeu-Farn Lin
Yeu-Farn Lin
XZXiang Zhou
Xiang Zhou
DBDaniel J. Bernard
Daniel J. Bernard
Discovery of a novel pituitary protein suggests a new means to enhance fertility.

18 January 2003 in Journal of Combinatorial Chemistry
Verified
Journal Article
Closed access
MGMeritxell Guinó
Meritxell Guinó
EBEmilie Brulé
Emilie Brulé
YMYolanda De Miguel
Yolanda De Miguel

25 May 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
GSGauthier Schang
Gauthier Schang
LOLuisina Ongaro
Luisina Ongaro
EBEmilie Brûlé
Emilie Brûlé
XZXiang Zhou
Xiang Zhou
YWYing Wang
Ying Wang
DBDaniel J. Bernard
Daniel J. Bernard
Mammalian reproduction depends on the gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone, which are secreted by pituitary gonadotrope cells. The zinc-finger transcription factor GATA2 was previously implicated in FSH production in male mice; however, its mechanisms of action and role in females were not determined. To directly address GATA2 function in gonadotropes, we generated and analyzed gonadotrope-specific Gata2 KO mice using the Cre-lox system. We found that while conditional KO (cKO) males exhibited ∼50% reductions in serum FSH levels and pituitary FSHβ subunit (Fshb) expression relative to controls, FSH production was apparently normal in cKO females. In addition, RNA-seq analysis of purified gonadotropes from control and cKO males revealed a profound decrease in expression of gremlin (Grem1), a bone morphogenetic protein (BMP) antagonist. We show Grem1 was expressed in gonadotropes, but not other cell lineages, in the adult male mouse pituitary. Furthermore, Gata2, Grem1, and Fshb mRNA levels were significantly higher in the pituitaries of WT males relative to females but decreased in males treated with estradiol and increased following ovariectomy in control but not cKO females. Finally, we found that recombinant gremlin stimulated Fshb expression in pituitary cultures from WT mice. Collectively, the data suggest that GATA2 promotes Grem1 expression in gonadotropes and that the gremlin protein potentiates FSH production. The mechanisms of gremlin action have not yet been established but may involve attenuation of BMP binding to activin type II receptors in gonadotropes, facilitating induction of Fshb transcription by activins or related ligands.

9 January 2023 in Endocrinology
Verified
Journal Article
Closed access
PDF file
EKEmily C Kappes
Emily C Kappes
CKChandramohan Kattamuri
Chandramohan Kattamuri
MCMagdalena Czepnik
Magdalena Czepnik
AYAlexander E Yarawsky
Alexander E Yarawsky
EBEmilie Brûlé
Emilie Brûlé
TTThomas B Thompson
Thomas B Thompson
Inhibins are transforming growth factor-β family heterodimers that suppress follicle-stimulating hormone (FSH) secretion by antagonizing activin class ligands. Inhibins share a common β chain with activin ligands. Follistatin is another activin antagonist, known to bind the common β chain of both activins and inhibins. In this study, we characterized the antagonist-antagonist complex of inhibin A and follistatin to determine if their interaction impacted activin A antagonism. We isolated the inhibin A:follistatin 288 complex, showing that it forms in a 1:1 stoichiometric ratio, different from previously reported homodimeric ligand:follistatin complexes, which bind in a 1:2 ratio. Small angle X-ray scattering coupled with modeling provided a low-resolution structure of inhibin A in complex with follistatin 288. Inhibin binds follistatin via the shared activin β chain, leaving the α chain free and flexible. The inhibin A:follistatin 288 complex was also shown to bind heparin with lower affinity than follistatin 288 alone or in complex with activin A. Characterizing the inhibin A:follistatin 288 complex in an activin-responsive luciferase assay and by surface plasmon resonance indicated that the inhibitor complex readily dissociated upon binding type II receptor activin receptor type IIb, allowing both antagonists to inhibit activin signaling. Additionally, injection of the complex in ovariectomized female mice did not alter inhibin A suppression of FSH. Taken together, this study shows that while follistatin binds to inhibin A with a substochiometric ratio relative to the activin homodimer, the complex can dissociate readily, allowing both proteins to effectively antagonize activin signaling.

8 September 2025 in Endocrinology
Verified
Journal Article
Open access
YLYeu-Farn Lin
Yeu-Farn Lin
EBEmilie Brûlé
Emilie Brûlé
LOLuisina Ongaro
Luisina Ongaro
XZXiang Zhou
Xiang Zhou
YJYangfan Jin
Yangfan Jin
DBDaniel J Bernard
Daniel J Bernard
Follicle-stimulating hormone (FSH) is an essential regulator of ovarian function. Inhibins are transforming growth factor β (TGFβ) family ligands produced in the gonads that suppress FSH synthesis by pituitary gonadotrope cells. Inhibins require a coreceptor, betaglycan or TGFBR3L, to mediate their actions. Female mice with a gonadotrope-specific knockout (KO) of betaglycan or global deletion of Tgfbr3l have increased FSH activity or levels and produce larger litters compared to controls. Females with both coreceptors knocked out (hereafter dKO) have dramatically increased circulating FSH, ovulate about 4 times as many eggs in natural cycles as controls but are infertile. Here, we show that dKO females show an increased number of implanted embryos at 7.5 days post coitum (dpc) but that their pregnancies fail around mid-gestation. Wild-type surrogates give birth to live young following transplantation of embryos from control or dKO females. Conversely, control but not dKO females can carry wild-type embryos to term, suggesting that the maternal environment in dKO mice cannot support full-term pregnancies. Elevated estradiol (E2) levels are deleterious to pregnancy in mice, and we detected increased E2 production in ovaries of pregnant dKOs. Treatment of these animals with aromatase inhibitors or a selective estrogen receptor degrader increased fetal survival. The results indicate that loss of inhibin action in murine gonadotropes results in excess E2 during pregnancy that precludes successful pregnancy.